Cleared Special

RESPIEVENTS SOFTWARE IS EVENT DATA PROCESSING SOFWARE FOR A PC (K012020) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K012020 · Non-Invasive Monitoring Systems, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2001
Decision
54d
Days
Class 2
Risk

K012020 is an FDA 510(k) clearance for the RESPIEVENTS SOFTWARE IS EVENT DATA PROCESSING SOFWARE FOR A PC. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Non-Invasive Monitoring Systems, Inc. (Miami Beach, US). The FDA issued a Cleared decision on August 21, 2001 after a review of 54 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Non-Invasive Monitoring Systems, Inc. devices

Submission Details

510(k) Number K012020 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 28, 2001
Decision Date August 21, 2001
Days to Decision 54 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
71d faster than avg
Panel avg: 125d · This submission: 54d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 184
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K012020.
CARDIOSOFT/CASE CARDIAC TESTING SYSTEM
K031561 · Ge Medical Systems Information Technologies · Aug 2003
LABSYSTEM III EP LABORATORY W/WINDOWS PLATFORM & WINDOWS EP SOFTWARE VERSION 1.0
K031000 · C.R. Bard, Inc. · Jun 2003
QUINTON Q-CATH, MODEL 000460
K021906 · Quinton, Inc. · Sep 2002
ASTRONOMER+WITH SLD
K003362 · Boston Scientific Corp · Mar 2001
STRESSWRITER EXERCISE TESTING SYSTEM
K961009 · Hewlett-Packard Co. · Jun 1996
ACCUSTRESS EXERCISE TESTING SYSTEM
K953127 · Hewlett-Packard Co. · Feb 1996